Compound Detail
CHEMBL254219
DIGITOXIN 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]5(C)[C@@H](C7=CC(=O)OC7)CC[C@]65O)C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O
Basic Information
| ChEMBL ID | CHEMBL254219 |
| Name | DIGITOXIN |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | WDJUZGPOPHTGOT-XUDUSOBPSA-N |
| Therapeutic | ✓ Yes |
32
Targets
53
Activities
4
Assay Types
7
PK Parameters
20
Publications
15
Known Names
2
Indications
1
Mechanisms
Molecular Properties
765.0
MW (Da)
3.25
ALogP
13
HBA
5
HBD
182.8
PSA (Ų)
0.19
QED
2
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1982 |
| Availability | Discontinued |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Sodium/potassium-transporting ATPase inhibitor | INHIBITOR | Sodium/potassium-transporting ATPase | ✓ | ✓ |
Indications
Cardiovascular Diseases Cystic Fibrosis
ATC Classification
C01AA04
digitoxin
Level 1: CARDIOVASCULAR SYSTEM
Level 2: CARDIAC THERAPY
Activity Summary
IC50 44 meas. best 8.49
Ki 6 meas. best 10.0
Kd 2 meas. best 9.22
EC50 1 meas. best 7.63
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Monoclonal antibody (mAb) CHEMBL613294 | Ki | 10.0 | 9.85 | 0.1 | 2 |
| Monoclonal antibody (mAb) CHEMBL613294 | Kd | 9.22 | 9.22 | 0.6 | 1 |
| TK-10 CHEMBL614056 | IC50 | 8.49 | 8.49 | 3.2 | 1 |
| K562 CHEMBL385 | IC50 | 8.19 | 8.19 | 6.4 | 1 |
| Sodium/potassium-transporting ATPase CHEMBL2095186 | IC50 | 8.1 | 8.1 | 8.0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-1 CHEMBL4838 | IC50 | 8.1 | 8.1 | 8.0 | 1 |
| MCF7 CHEMBL387 | IC50 | 7.99 | 7.35 | 10.2 | 3 |
| Unchecked CHEMBL612545 | IC50 | 7.96 | 6.9 | 11.0 | 8 |
| Human betaherpesvirus 5 CHEMBL371 | EC50 | 7.63 | 7.63 | 23.3 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-2/beta-3 CHEMBL6066562 | Ki | 7.54 | 7.54 | 28.8 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-2/beta-1 CHEMBL6066560 | Ki | 7.53 | 7.53 | 29.5 | 1 |
| UACC-62 CHEMBL614610 | IC50 | 7.47 | 7.47 | 33.5 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-2/beta-2 CHEMBL6066561 | Ki | 7.39 | 7.39 | 40.7 | 1 |
| MDA-MB-435 CHEMBL614697 | IC50 | 7.37 | 7.365 | 43.0 | 2 |
| HT-29 CHEMBL384 | IC50 | 7.17 | 6.5767 | 67.6 | 3 |
| OVCAR-8 CHEMBL612555 | IC50 | 7.15 | 7.15 | 71.5 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-1/beta-1 CHEMBL6066559 | Ki | 7.05 | 7.05 | 89.0 | 1 |
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 7.0 | 6.5833 | 100.0 | 3 |
| OVCAR-3 CHEMBL614213 | IC50 | 6.93 | 6.925 | 117.1 | 2 |
| Solute carrier organic anion transporter family member 4C1 CHEMBL2073690 | IC50 | 6.92 | 6.92 | 120.0 | 1 |
| OVCAR-5 CHEMBL614214 | IC50 | 6.49 | 6.49 | 321.0 | 1 |
| NCI-H460 CHEMBL396 | IC50 | 6.45 | 6.405 | 357.0 | 2 |
| OVCAR-4 CHEMBL614051 | IC50 | 6.37 | 6.37 | 425.6 | 1 |
| SK-OV-3 CHEMBL614925 | IC50 | 6.36 | 6.36 | 440.0 | 1 |
| SF-268 CHEMBL613977 | IC50 | 6.36 | 6.36 | 440.0 | 1 |
| NCI/ADR-RES CHEMBL613829 | IC50 | 6.36 | 6.36 | 440.0 | 1 |
| DU-145 CHEMBL613508 | IC50 | 6.36 | 6.36 | 440.0 | 1 |
| A549 CHEMBL392 | IC50 | 6.36 | 6.36 | 440.0 | 1 |
| HCT-116 CHEMBL394 | IC50 | 6.36 | 6.245 | 440.0 | 2 |
| MDA-MB-231 CHEMBL400 | IC50 | 6.32 | 6.32 | 480.0 | 2 |
| Signal transducer and activator of transcription 3 CHEMBL4026 | IC50 | 6.16 | 6.16 | 700.0 | 1 |
| KURAMOCHI CHEMBL2366119 | IC50 | 5.23 | 5.23 | 5911.0 | 1 |
| Unchecked CHEMBL612545 | Kd | 4.55 | 4.55 | 28000.0 | 1 |
| Bile salt export pump CHEMBL6020 | IC50 | 4.51 | 4.51 | 31000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 0.043 | mL.min-1.kg-1 | Homo sapiens |
| F | 88.5 | % | Homo sapiens |
| Fu | 0.066 | - | Homo sapiens |
| MRT | 170.0 | hr | Homo sapiens |
| T1/2 | 0.245 | hr | - |
| T1/2 | 0.7183 | hr | - |
| T1/2 | 180.0 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL3885881 | Rattus norvegicus | 526 |
| 28234008 | 10.1021/acs.jnatprod.6b01150 | Unchecked | 15 |
| 12109909 | 10.1021/jm0102811 | Monoclonal antibody (mAb) | 8 |
| 28234008 | 10.1021/acs.jnatprod.6b01150 | OVCAR-3 | 6 |
| 24900847 | 10.1021/ml400529q | HFF | 6 |
| 24900847 | 10.1021/ml400529q | Human betaherpesvirus 5 | 5 |
| 18426954 | 10.1124/dmd.108.020479 | ADMET | 4 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| 19894733 | 10.1021/np900210m | HT-29 | 4 |
| 19894733 | 10.1021/np900210m | NON-PROTEIN TARGET | 4 |
| 16309315 | 10.1021/np050226l | TK-10 | 4 |
| 20014752 | 10.1021/tx900326k | Hepatotoxicity | 3 |
| 19894733 | 10.1021/np900210m | HCT-116 | 3 |
| 16309315 | 10.1021/np050226l | DNA topoisomerase 2-beta | 3 |
| 16309315 | 10.1021/np050226l | DNA topoisomerase 2-alpha | 3 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 2 |
| 7143360 | 10.1021/jm00352a025 | ADMET | 2 |
| 141522 | 10.1021/jm00216a022 | Unchecked | 2 |
| 21643465 | 10.1021/ml100219d | NCI-H460 | 2 |
| 18834112 | 10.1021/jm800656v | Amine oxidase [flavin-containing] A | 2 |
Data from ChEMBL 36 via Core Engine